By Alfonso Serrano — 2017
MDMA-assisted psychotherapy readies for phase III trials, a last step before possible prescription use in PTSD patients.
Read on www.scientificamerican.com
CLEAR ALL
Scientists test how pharmaceutical-grade MDMA combines with psychotherapy to help patients with a severe form of PTSD.
A new review of studies finds that LSD, psilocybin, and MDMA hold potential for treating mental illness.
1
The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.